FY25 HEPLISAV-B net product revenue is expected in the range of $305M to $325M
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DVAX:
Education
About Us
Working with TipRanks
Follow Us
